Discover how rheumatoid arthritis advances through distinct stages, the symptoms at each phase, and treatment approaches that ...
Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...
This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...
Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, ...
Zacks Small Cap Research on MSN2h
INAB: Introducing INB-600, A γδ T Cell Engager PlatformINAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback